The FDA has issued an approvable letter to LDR for its Mobi-C system, a metal and polyethylene mobile bearing prosthetic device tailored for use in one- to two-level cervical disc replacement procedures. The company expects to satisfy the remaining approval requirements and release the device in the U.S. next year.
LDR closer to FDA approval for cervical disc device
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|